Mirae Asset Global ETFs Holdings’s Vera Therapeutics VERA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.63M	Buy	37,844 +1,610	+4%	+$60K	﹤0.01%	1364
2026 Q1	$1.44M	Buy	36,234 +5,437	+18%	+$234K	﹤0.01%	1341
2025 Q4	$1.56M	Buy	30,797 +2,414	+9%	+$85.7K	﹤0.01%	1275
2025 Q3	$824K	Sell	28,383 -3,338	-11%	-$77.2K	﹤0.01%	1606
2025 Q2	$744K	Buy	31,721 +816	+3%	+$18.3K	﹤0.01%	1594
2025 Q1	$753K	Buy	30,905 +2,210	+8%	+$71K	﹤0.01%	1637
2024 Q4	$1.21M	Buy	28,695 +7,378	+35%	+$327K	﹤0.01%	1453
2024 Q3	$942K	Sell	21,317 -4,418	-17%	-$168K	﹤0.01%	1572
2024 Q2	$924K	Buy	+25,735	New	+$1.02M	﹤0.01%	1500

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's VERA Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Vera Therapeutics (VERA) stake by 4.4% in Q2 2026, buying an estimated $60K and bringing the position to 37,844 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #1364.

Mirae Asset Global ETFs Holdings first reported a position in VERA in Q2 2024 and has held it in 9 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

Mirae Asset Global ETFs Holdings held 37,844 shares of Vera Therapeutics worth $1.63M as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 1,610 Vera Therapeutics shares in Q2 2026, an estimated $60K.
Vera Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1364 holding.
Mirae Asset Global ETFs Holdings first reported a position in Vera Therapeutics in Q2 2024 and has held it in 9 quarters since.
219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.